نتائج البحث

Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study.

• Authors : Ye, Hua¹ (AUTHOR); Liu, Shengyun² (AUTHOR); Xu, Jian³ (AUTHOR)

• Source: Rheumatology & Therapy. Jun2023, Vol. 10 Issue 3, p757-773. 17p.

تفاصيل العنوان

Comparative efficacy and safety of biosimilar-infliximab and originator-infliximab in combination with methotrexate in patients with active rheumatoid arthritis: a meta-analysis of randomized controlled trials.

• Authors : Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.; Lee YH

Subjects: Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Biological Products/Biological Products/Biological Products/*therapeutic use ; Biosimilar Pharmaceuticals/Biosimilar Pharmaceuticals/Biosimilar Pharmaceuticals/*therapeutic use

• Source: International journal of rheumatic diseases [Int J Rheum Dis] 2018 May; Vol. 21 (5), pp. 922-929. Date of Electronic Publication: 2018 Apr 19.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

تفاصيل العنوان

inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease (DIRECTCD)

• Authors : Celltrion; Krisztina Gecse, Medical Docter IBD specialist

• Source: A Multicenter Randomized, Open-label Study to Compare the Efficacy of Subcutaneous Infliximab Monotherapy With Subcutaneous Infliximab and

تفاصيل العنوان

Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease.

• Authors : Strik AS; Department of Gastroenterology, Academic Medical Centre Amsterdam, Amsterdam, the Netherlands.; van den Brink GR

Subjects: Adalimumab/Adalimumab/Adalimumab/*immunology ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*blood ; Immunologic Factors/Immunologic Factors/Immunologic Factors/*administration & dosage

• Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2017 Apr; Vol. 45 (8), pp. 1128-1134. Date of Electronic Publication: 2017 Feb 23.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy (SPARE)

• Authors : Saint-Louis Hospital, Paris, France

• Source: A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and

تفاصيل العنوان

Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study.

• Authors : Liu, Yanying^1,2 (AUTHOR); Liu, Shengyun³ (AUTHOR); Liu, Lin⁴ (AUTHOR)

• Source: Rheumatology & Therapy. Feb2022, Vol. 9 Issue 1, p175-189. 15p.

تفاصيل العنوان

Protective effect of infliximab on methotrexate-induced liver injury in rats: unexpected drug interaction.

• Authors : Cure E; Department of Internal Medicine, School of Medicine, Recep Tayyip Erdogan University, Rize, Turkey.; Kirbas A

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*adverse effects ; Chemical and Drug Induced Liver Injury/Chemical and Drug Induced Liver Injury/Chemical and Drug Induced Liver Injury/*pathology ; Infliximab/Infliximab/Infliximab/*pharmacology

• Source: Journal of cancer research and therapeutics [J Cancer Res Ther] 2015 Jan-Mar; Vol. 11 (1), pp. 164-9.Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print Cited Medium: Internet ISSN: 1998-4138

تفاصيل العنوان

A Novel Case of Multicentric Reticulohistiocytosis Associated with Renal Cell Carcinoma Successfully Treated with Infliximab and Methotrexate.

• Authors : Patel, Suraj¹ (AUTHOR); Alhajj, Mandy² (AUTHOR); Brimhall, Conrad L³ (AUTHOR)

• Source: Case Reports in Dermatology. 2023, Vol. 15 Issue 1, p10-16. 7p.

تفاصيل العنوان

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab.

• Authors : Dénarié D; Department of Rheumatology, CHU Saint-Etienne, Saint-Etienne, France.; Rinaudo-Gaujous M

Subjects: Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Infliximab/Infliximab/Infliximab/*therapeutic use

• Source: Mediators of inflammation [Mediators Inflamm] 2017; Vol. 2017, pp. 3708250. Date of Electronic Publication: 2017 Mar 02.Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 9209001 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.

• Authors : Tarkiainen M; Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland. .; Pediatric Research Center, University of Helsinki, Helsinki, Finland. .

Subjects: Quality of Life*; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Juvenile/Arthritis, Juvenile/Arthritis, Juvenile/*drug therapy

• Source: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2019 Dec 16; Vol. 17 (1), pp. 80. Date of Electronic Publication: 2019 Dec 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101248897 Publication Model: Electronic Cited Medium: Internet ISSN: 1546-0096

تفاصيل العنوان